Free radical release in C6 glial cells enriched in hexacosanoic acid: Implication for X-linked adrenoleukodystrophy pathogenesis

Neurochemistry International

Volumn 44, Issue 4, 2004, Pages 215-221

  Di Biase, Antonella ^a   Di Benedetto, Rita ^a   Fiorentini, Carla ^a   Travaglione, Sara ^a   Salvati, Serafina ^a   Attorri, Lucilla ^a   Pietraforte, Donatella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Adrenoleukodystrophy; C6 cells; Hexacosanoic acid; Nitrites; Oxidative stress; Superoxide

Indexed keywords

ACID; CYTOKINE; ENDOTOXIN; FREE RADICAL; HEXACOSENOIC ACID; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE; NITRITE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ANIMAL CELL; ARTICLE; BIOACCUMULATION; BRAIN INJURY; CELL ACTIVITY; CELL FUNCTION; CONTROLLED STUDY; GLIA CELL; HYPOTHESIS; IN VITRO STUDY; INTRACELLULAR SPACE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SUPERNATANT;

BACTERIA (MICROORGANISMS);

EID: 0242268078     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00162-1     Document Type: Article

References (51)

1. Abe K., Pan L.H., Watanabe T., Kato Y., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199:1995;152-154.
2. Aubourg P., Mandel J.L. X-linked adrenoleukodystrophy. Ann. N. Y. Acad. Sci. 804:1996;461-476.
3. Aubourg P., Dubois-Dalq M. How does the ALD peroxisomal transporter mutation affect CNS glia? Glia. 29:2000;186-190.
4. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide and peroxinitrite: the good, the bad and ugly. Am. J. Physiol. 271:1996;C1424-C1437.
5. Bhat N.R., Zhang P., Bhat A.N. Cytokine induction of inducible nitric oxide synthase in an oligodendrocyte cell line: role of p. 38 mitogen activated protein kinase activation. J. Neurochem. 72:1999;472-478.
6. Bromberg Y., Pick E. Unsaturated fatty acids as second messengers of superoxide generation by macrophages. Cell. Immunol. 79:1983;240-252.
7. Calder P.C., Grimble R.F. Polyunsaturated fatty acids, inflammation and immunity. Eur. J. Clin. Nutr. 56:2002;S14-S19.
8. Curnutte J.T., Badwey J.A., Robinson J.M., Karnovsky M.J., Karnowsky M.L. Studies on the mechanism of superoxide release from human neutrophils stimulated with arachidonate. J. Biol. Chem. 259:1984;11851-11857.
9. Dawson V.L., Dawson T.M. Nitric oxide in neuronal degeneration. Proc. Soc. Exp. Biol. Med. 211:1996;33-40.
10. Di Biase A., Salvati S., Varì R., Avellino C., Sforza F., Cappa M., Masella R. Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: effects of simvastatin treatment. Mol. Genet. Metabol. 71:2000;651-655.
11. Di Biase A., Salvati S., Attorri L., Pietraforte D. Consideration on X-Linked adrenoleukodystrophy phatogenesis. Recent Res. Dev. Neurochem. 5:2002;49-56.
12. Feinstein D.L., Galea E., Roberts S., Berquits H., Wang H., Reis D.J. Induction of nitric oxide synthase in rat C6 glioma cells. J. Neurochem. 62:1994;315-321.
13. Gilg A.G., Singh A.K., Singh I. Inducible nitric oxide synthase in the central nervous system of patients with X-adrenoleukodystrophy. J. Neurophatol. Exp. Neurol. 59:2000;1063-1069.
14. Griffin D.E., Moser H.W., Mendoza Q., Moench T., O'Toole S., Moser A.B. Identification of the inflammatory cells in the nervous system of patients with adrenoleukodystrophy. Ann. Neurol. 18:2000;660-664.
15. 2 and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide. 5:2001;504-513.
16. Hardy S.J., Ferrante A., Poulos A., Robinson B.S., Johnson D.W., Murray A.W. Effect of exogenous fatty acids with greater than 22 carbon atoms (very long chain fatty acids) on superoxide production by human neutrophils. J. Immunol. 153:1994;1754-1761.
17. Ho J.K., Moser H., Kishimoto Y., Hamilton J.A. Interactions of very long chain fatty acid with model membrane and serum albumin. J. Clin. Invest. 96:1995;1455-1463.
18. Huang A., Li C., Kao R.L., Stone W.L. Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages. Free Radic. Biol. Med. 26:1999;526-537.
19. Liu D., Wen J., Liu J., Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. 13:1999;2318-2328.
20. Liu W., Kato M., Itoigawa M., Murakami H., Yajima M., Wu J., Ishikawa N., Nakashima I. Distint involvement of NF-kappa B and p38 mitogen-activated protein kinase pathways in serum deprivation mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J. Cell. Biochem. 83:2001;271-280.
21. Luciani G.B., Pessotto R., Mazzucco A. Adrenoleukodystrophy presenting as postperfusion syndrome (letter). N. Engl. J. Med. 336:1997;731-732.
22. Manning P., Cookson M.R., McNeil C.J., Figlewicz D., Shaw P.J. Superoxide-induced nitric oxide release from cultured glial cells. Brain Res. 911:2001;203-210.
23. Markesbery W.R. Oxidative stress hypothesis in Alzahemer's disease. Free Radic. Biol. Med. 23:1997;134-147.
24. Masella R., Cantafora A., Modesti D., Cardilli A., Gennaro L., Bocca A., Coni E. Antioxidant activity of 3,4-DHPEA-EA and protocatecuic acid: a comparative assessment with other olive oil biophenols. Redox Rep. 4:1999;113-121.
25. Mayer B. Nitric oxide synthases catalyze superoxide formation. FEBS Lett. 24110:2000;1.
26. McCann M.E., Moore J.N., Carrick J.B., Barton M.H. Effect of intravenous of omega-3 and omega-6 lipid emulsions on equine monocyte fatty acid composition and inflammatory mediator production in vitro. Shock. 14:2000;222-228.
27. McGuiness M.C., Griffin D.E., Raymond G.V., Washington C.A., Moser H.W., Smith K.D. Tumor necrosis factor-α and X-linked adrenoleukodystrophy. J. Neuroimmunol. 61:1995;161-169.
28. Merrill J.E., Ignarro L.J., Sherman P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
29. Mollace V., Nisticò G. E. choli lipopolysaccaride enhances the release of NO-like factor from astrocytoma cells in culture. Prog. Neuroendocrinimmunol. 5:1992;102-107.
30. Moser H.W. Adrenoleukodystrophy: phenotype, genetics pathogenesis and therapy. Brain. 120:1997;1486-1508.
31. Mosmann T. Rapid colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
32. Mosser J., Donar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.M., Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 361:1993;726-730.
33. Murphy S., Simmons M.L., Agullo L., Garcia A., Feinstein D.L., Galea E., Reis D.J., Minc-Colomb D., Schwartz J. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16:1993;323-328.
34. Nishya T., Uehara T., Kaneko M., Nomura Y. Involvement of nuclear factor-kB (NF-kB) signaling in the expression of inducible nitric oxide synthase (iNOS) gene in rat C6 glioma cells. Biochem. Biophys. Res. Commun. 275:2000;268-273.
35. Parkinson J.F., Mitrovic B., Merrill J.E. The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75:1997;174-186.
36. Patel R.P., McAndrew J., Sellak H., White C.R., Jo H., Freeman B.A., Darley-Usmar V.M. Biological aspects of reactive nitrogen species. Biochim. Biophys. Acta. 1411:1999;385-400.
37. Powers J.M., De Ciero D.P., Moser H.W., Moser A.B. Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy. J. Neuropathol. Exp. Neurol. 59:2000;89-102.
38. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J.L. Late-onset neurological phenotype of X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 11:2002;499-505.
39. Ravid S., Diamond A.S., Eviatar L. Coma as an acute presentation of adrenoleukodystrophy. Pediatric Neurol. 22:2000;237-239.
40. Richter-Landsberg C., Vollgraf U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp. Cell Res. 244:1998;218-229.
41. Robert J., Montaudon D., Hugues P. Incorporation and metabolism of exogenous fatty acids by cultured normal and tumoral glial cells. Biochim. Biophys. Acta. 752:1983;383-395.
42. Roser K., Bohn W., Giese G., Mannweiler K. Subclones of C6 rat glioma cells differing in intermediate filament protein expression. Exp. Cell Res. 197:1991;200-206.
43. Saito M., Saito M. Incorporation of very long chain fatty acids into sphingolipids of cultured neuronal cells. J. Neurochem. 57:1991;465-469.
44. Smith K.J., Fapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9:1999;69-92.
45. Smith M.A., Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxinitrite mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
46. 2 - generating system in a cell-free preparation from neutrophils. J. Biol. Chem. 263:1988;13670-13676.
47. Tarpey M.M., Fridovich I. Methods of detection of vascular reactive species. Circ. Res. 89:2001;224-236.
48. Wanders R.J.A., Van Roermud C.W.T., Van Wijland M.J.A., Schutgens R.B.H., Van den Bosch H., Shram A.W., Tager J.M. Direct evidence that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids. Biochem. Biophys. Res. Commun. 153:1988;618-624.
49. Watkins P.A., Gould S.J., Smith M.A., Braiterman L.T., Moser H.W. Altered expression of ALDP in X-linked adrenoleukodystrophy. Ann. Hum. Genet. 57:1995;292-301.
50. Wilkinson J.A., Hopkins I.J., Pollard A.C. Can head trauma influence the site of demyelination in adrenoleukodystrophy. Dev. Med. Child Neurol. 29:1987;797-800.
51. Zhang J., Jhonston G., Stebler B., Keller E.T. Hydrogen peroxide activates NF-kappa B and the interleukin-6 promoter through NF kappa B-inducing kinase. Antioxidant Redox Signal. 3:2001;493-504.